Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rescentris was a life science informatics company that developed the Collaborative Electronic Research Framework (CERF), a cross-platform electronic laboratory notebook (ELN). The software was designed to help research organizations manage scientific data, protect intellectual property, and ensure regulatory compliance with standards such as 21 CFR Part 11. Rescentris served a diverse client base including academic institutions, government agencies like the NIH, and private biotechnology firms. In 2013, the company's assets and the CERF ELN product line were acquired by Lab-Ally, which continues to maintain and evolve the technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rescentris.